Učitavanje...
Alendronate for osteoporosis. Safe and efficacious nonhormonal therapy.
OBJECTIVE: To review the evidence concerning alendronate (Fosamax) therapy for postmenopausal osteoporosis. QUALITY OF EVIDENCE: The efficacy of alendronate for postmenopausal women with osteoporosis was primarily demonstrated by two primary phase III clinical trials, three other 2-year trials, and...
Spremljeno u:
Glavni autor: | |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
College of Family Physicians of Canada
1998
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2277603/ https://ncbi.nlm.nih.gov/pubmed/9512836 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|